Wealth Bridge Investment Counsel Inc. Gilead Sciences, Inc. Transaction History

Wealth Bridge Investment Counsel Inc.

$270 Million
Q1 2024

A detailed history of Wealth Bridge Investment Counsel Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wealth Bridge Investment Counsel Inc. holds 74,055 shares of GILD stock, worth $4.94 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares

74,055

Previous 77,305 4.2%

Holding current value

$4.94 Million

Previous $6.26 Million 13.37%

% of portfolio

2.01%

Previous 2.5%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$71.58 - $87.29 $232,635 - $283,692	-3,250 Reduced 4.2%	74,055 $5.43 Million
Q4 2023 Jan 17, 2024	SELL	$73.27 - $83.09 $62,279 - $70,626	-850 Reduced 1.09%	77,305 $6.26 Million
Q3 2023 Oct 17, 2023	SELL	$73.94 - $80.67 $18,485 - $20,167	-250 Reduced 0.32%	78,155 $5.86 Million
Q2 2023 Jul 26, 2023	BUY	$76.01 - $86.7 $15,202 - $17,340	200 Added 0.26%	78,405 $6.04 Million
Q1 2023 Apr 18, 2023	SELL	$77.31 - $88.08 $65,713 - $74,868	-850 Reduced 1.08%	78,205 $6.49 Million

Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $105,944 - $152,099	1,700 Added 2.2%	79,055 $6.79 Million
Q3 2022 Oct 13, 2022	BUY	$59.54 - $68.01 $196,482 - $224,433	3,300 Added 4.46%	77,355 $4.77 Million
Q2 2022 Jul 26, 2022	SELL	$57.72 - $65.01 $46,176 - $52,008	-800 Reduced 1.07%	74,055 $4.58 Million
Q1 2022 Apr 05, 2022	SELL	$57.92 - $72.58 $15,059 - $18,870	-260 Reduced 0.35%	74,855 $4.45 Million
Q4 2021 Jan 24, 2022	BUY	$64.88 - $73.64 $84,344 - $95,732	1,300 Added 1.76%	75,115 $5.45 Million
Q3 2021 Oct 20, 2021	SELL	$67.69 - $73.03 $6,769 - $7,303	-100 Reduced 0.14%	73,815 $5.16 Million
Q2 2021 Aug 03, 2021	BUY	$63.47 - $69.35 $174,542 - $190,712	2,750 Added 3.86%	73,915 $5.09 Million
Q1 2021 Apr 26, 2021	BUY	$60.0 - $68.46 $15,000 - $17,115	250 Added 0.35%	71,165 $4.6 Million
Q4 2020 Feb 03, 2021	BUY	$56.65 - $64.55 $362,560 - $413,120	6,400 Added 9.92%	70,915 $4.13 Million
Q3 2020 Oct 30, 2020	BUY	$62.1 - $78.08 $66,757 - $83,936	1,075 Added 1.69%	64,515 $4.08 Million
Q2 2020 Aug 06, 2020	BUY	$72.34 - $84.0 $50,638 - $58,800	700 Added 1.12%	63,440 $6.65 Million
Q1 2020 Apr 20, 2020	BUY	$62.63 - $80.22 $93,945 - $120,330	1,500 Added 2.45%	62,740 $4.69 Million
Q4 2019 Jan 23, 2020	BUY	$61.62 - $67.78 $3.77 Million - $4.15 Million	61,240 New	61,240 $3.98 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Bridge Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wealth Bridge Investment Counsel Inc. with notifications on news.

Account

Wealth Bridge Investment Counsel Inc. Gilead Sciences, Inc. Transaction History